Endogenex

Treating the gut may redefine what's possible in diabetes care.

[Endogenex @endogenex]

Excited to present REGENT-1 study data at #ADA2025 this week in Chicago!
New findings highlight the potential of our pulsed electric field (PEF) system to impact:
✅ Insulin sensitivity
✅ Beta cell function
✅ Dose responsivity

#Type2Diabetes #Endogenex #ReCETStudy

[Endogenex @endogenex]

Groundbreaking data at #DDW2025:
AI-driven 3D spatial analysis reveals profound immune dysregulation and structural remodeling in T2D duodenums.
Presented by @babudayyeh, the first-of-its-kind abstract marks a major advance in understanding diabetic duodenopathy.
#T2D #duodenum

[Endogenex @endogenex]

@babudayyeh presented 48-week outcomes from REGENT-1 study at #DDW2025, highlighting sustained improvement in insulin sensitivity & beta cell function following non-thermal PEF treatment of the duodenum.
More to come from San Diego!

#T2D #Endocrinology #diabetictduodenopathy

[Mayo Clinic Studies @MayoStudies]

Mayo Clinic researchers are seeking volunteers ages 22-70 with a BMI between 27-40 for a randomized study of a device used for the treatment of type 2 diabetes. Contact [email protected] or visit https://t.co/4XSIDysRQi for information.

[Endogenex @endogenex]

Endogenex is adding to its leadership team. We are excited to announce Krissy Wright as the new Chief Financial Officer.
https://t.co/cR2lEIVkkE
#diabetes #GItwitter

[Endogenex @endogenex]

Exciting News! Endogenex announces enrollment of the first patient in the ReCET Clinical Study.

Led by Dr. Andre Teixeira at Orlando Health, this milestone marks a significant step in our mission to transform diabetes care. Read more in our press release below. 👇

[Barham Abu Dayyeh MD MPH FASGE FAGA FAFS @babudayyeh]

A new paradigm suggesting that the integrative function of the duodenum in orchestrating the metabolic response is altered in metabolic diseases due to inflammation. This could represent a novel, potentially disease-modifying therapeutic target for type II diabetes. #diabetes2 #duodenum

[Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep]

@babudayyeh presenting cutting-edge data on endoscopic therapy approaches to #diabetes management
A glimpse into the future!
@DDWMeeting #DDW2024

[Endogenex @endogenex]

Knowing the risk for Type 2 Diabetes & being diagnosed is half the battle.
Today is World Diabetes Day. One in ten adults worldwide have diabetes, yet close to half are undiagnosed.
#Endogenex supports awareness, prevention, & improved treatment options for people with #T2D

[Endogenex @endogenex]

November is Diabetes Awareness Month-time to bring to light the challenges faced by people worldwide living with #diabetes. From prevention to the search for alternative treatment options, the #endogenex team supports improved outcomes & quality of life for those living with #T2D

[Endogenex @endogenex]

EMINENT Clinical Study data being presented today at The European Association for the Study of Diabetes #EASD2023. @CelineBusch, MD et al. oral abstract highlights 12-month results in patients treated with the ReCET™ System
https://t.co/qcwXkpud1Q
#type2diabetes #GITwitter

[Endogenex @endogenex]

ReCET Procedure in people with T2D was highlighted at the #ADA2023 . Data from REGENT-1 & EMINENT clinical studies outline early safety & feasibility experience. Thank you to Investigators from Australia, The Netherlands, & USA for your work in these studies.

[Endogenex @endogenex]

https://t.co/cP8QZ1Q8Ji #ADA2023

[Endogenex @endogenex]

https://t.co/PJFJxwxY0w #ADA2023

[Endogenex @endogenex]

https://t.co/qdvalf3vfn

[Endogenex @endogenex]

Next up #ADA2023 from June 23 - 26 in San Diego. #type2diabetes #ReCET #diabetesmanagement #gastroenterology

[Endogenex @endogenex]

#type2diabetes #ReCET #diabetesmanagement #gastroenterology #GItwitter #HereforDDW

[medtech MVP (Conference) @MedtechTalk]

Geoff Pardo and Stacey Pugh talk about Stacey’s career that began at the bedside as a trauma nurse and is now leading the charge at @Endogenex to take a new approach to Type 2 Diabetes treatment. Listen to the conversation: https://t.co/njrNjSufav

[Endogenex @endogenex]

@endogenex CEO, Stacey Pugh, shares her career experience in Med Tech, vision for Endogenex, and its mission for improving outcomes in people with Type 2 Diabetes.

https://t.co/bzdoRo1nxg

[Drug Delivery Business News @DrugDeliveryNow]

#Endogenex, developer of a procedure for treating type 2 #diabetes, announced today that it appointed Stacey Pugh as its new CEO.

More from @endogenex, HERE: https://t.co/IA9n7QG6LS

#Surgical #Finance